Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 1
1975 2
1977 1
1985 2
1986 2
1992 1
1993 3
1994 5
1995 3
1996 1
1997 3
1998 7
1999 6
2000 6
2001 4
2002 5
2003 8
2004 9
2005 5
2006 6
2007 8
2008 3
2009 10
2010 10
2011 8
2012 17
2013 18
2014 7
2015 8
2016 11
2017 17
2018 12
2019 15
2020 18
2021 14
2022 14
2023 20
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Results by year

Filters applied: . Clear all
Page 1
Translational control of stem cell function.
Saba JA, Liakath-Ali K, Green R, Watt FM. Saba JA, et al. Nat Rev Mol Cell Biol. 2021 Oct;22(10):671-690. doi: 10.1038/s41580-021-00386-2. Epub 2021 Jul 16. Nat Rev Mol Cell Biol. 2021. PMID: 34272502 Review.
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr; Regain Study Group. Muppidi S, et al. Muscle Nerve. 2019 Jul;60(1):14-24. doi: 10.1002/mus.26447. Epub 2019 Mar 8. Muscle Nerve. 2019. PMID: 30767274 Free PMC article.
EDF1 coordinates cellular responses to ribosome collisions.
Sinha NK, Ordureau A, Best K, Saba JA, Zinshteyn B, Sundaramoorthy E, Fulzele A, Garshott DM, Denk T, Thoms M, Paulo JA, Harper JW, Bennett EJ, Beckmann R, Green R. Sinha NK, et al. Among authors: saba ja. Elife. 2020 Aug 3;9:e58828. doi: 10.7554/eLife.58828. Elife. 2020. PMID: 32744497 Free PMC article.
Sphingosine Phosphate Lyase Insufficiency Syndrome.
Weaver KN, Sullivan B, Hildebrandt F, Strober J, Cooper M, Prasad R, Saba J. Weaver KN, et al. Among authors: saba j. 2020 Oct 15. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2020 Oct 15. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 33074640 Free Books & Documents. Review.
Bursting translation on single mRNAs in live cells.
Livingston NM, Kwon J, Valera O, Saba JA, Sinha NK, Reddy P, Nelson B, Wolfe C, Ha T, Green R, Liu J, Wu B. Livingston NM, et al. Among authors: saba ja. Mol Cell. 2023 Jul 6;83(13):2276-2289.e11. doi: 10.1016/j.molcel.2023.05.019. Epub 2023 Jun 16. Mol Cell. 2023. PMID: 37329884
Sphingosine phosphate lyase insufficiency syndrome: a systematic review.
Pournasiri Z, Madani A, Nazarpack F, Sayer JA, Chavoshzadeh Z, Nili F, Tran P, Saba JD, Jamee M. Pournasiri Z, et al. Among authors: saba jd. World J Pediatr. 2023 May;19(5):425-437. doi: 10.1007/s12519-022-00615-4. Epub 2022 Nov 12. World J Pediatr. 2023. PMID: 36371483 Review.
270 results